Tag: Catalyst Biosciences
April 1, 2019
Catalyst Biosciences Rises on European Orphan Designation
Shares of Catalyst Biosciences were up over 10 percent on Monday after it received orphan designation from the European Commission. February 8, 2019
Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa
Catalyst Biosciences (NASDAQ:CBIO) has announced it has presented updated interim data from its Phase 2/3 trial of subcutaneous prophylactic Factor VIIa... February 6, 2019